Search results
5 FDA decisions to watch in the third quarter
BioPharma Dive· 9 hours agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...
Johnson & Johnson reports data from Phase III multiple myeloma treatment trial
Clinical Trials Arena· 10 hours agoThe randomised study is designed to assess the efficacy and safety of CARVYKTI against...
Bytes Of Healing: Digital Innovation Meets Patient-Centric Care Through AI/ML
Free Press Journal· 6 hours agoIn the evolving landscape of healthcare, digital innovation powered by Artificial Intelligence (AI) ...
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Pharmaceutical Technology· 4 hours agoThe deal, which was agreed upon in May this year and includes $650m in milestone payments, sees...
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 19 hours agoFederal policymakers must continue increasing investments in Alzheimer’s disease research and support services for caregivers to provide help and ...
New gene editing tool to cure rare disorders | Hyderabad News - Times of India
The Times of India· 20 hours agoand Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB) in New Delhi and the LV Prasad Eye Institute (LVPEI ...
TGH enters partnership to enhance pulmonary care in Florida, US
Hospital Management· 5 hours agoFollowing complex treatments at TGH, patients can conveniently follow up with their TGH PCSI...
USFDA approves second Alzheimer's drug that can modestly slow disease
Business Standard India· 17 hours agoUS officials have approved another Alzheimer's drug that can modestly slow the disease, providing a...
EAN 2024: Benefits of early migraine treatment clear but implementation remains challenging
Clinical Trials Arena· 4 hours agoA further key challenge highlighted during the symposium is that due to the variability of migraine...
Once-in-a-week insulin jab nears approval in India: Report
CNBC Awaaz· 16 hours agoInsulin Icodec, the first weekly insulin jab from Novo Nordisk, which also makes weight-loss drug...